Sign in

You're signed outSign in or to get full access.

XG

XBP Global Holdings, Inc. (XBP)·Q3 2025 Earnings Summary

Executive Summary

  • Q3 2025 pro forma revenue was $220.4M, down 18.1% year over year; excluding a $36.5M one-time client notification project in Q3’24, underlying decline was 8.3%, while pro forma gross margin expanded 190 bps to 21.9% and pro forma adjusted EBITDA rose 7.1% to $24.7M with margin up 260 bps to 11.2% .
  • As reported revenue (partial-quarter consolidation) was $209.1M, down 10.4% YoY; as-reported gross margin improved 310 bps to 22.0% .
  • Management highlighted new wins (NYC Department of Finance lockbox and a multi-year insurance re-mail processing contract) and signaled moderating declines as pipeline rebuilds; no formal guidance was provided this quarter .
  • Strategic context: XBP Europe’s acquisition of Exela BPA closed July 29; pro forma TTM revenue is ~$916.4M with adjusted EBITDA ~$103.6M and net leverage of ~3.37x (below Russell 2000 average), providing scale and balance sheet strength .

What Went Well and What Went Wrong

  • What Went Well

    • Margin expansion driven by automation and operating leverage: pro forma gross margin +190 bps YoY to 21.9%; adjusted EBITDA margin +260 bps YoY to 11.2% .
    • Strategic wins and pipeline momentum: “we've announced a number of exciting new contracts… New York City Department of Finance… large insurance carrier” and the “revenue declines are beginning to moderate” .
    • AI execution delivering efficiency gains: “automation rate of up to 70%-75% using our intelligent document processing IDP workflow” and revenue per employee >$80k vs peers ~$57k .
  • What Went Wrong

    • Top-line pressure: pro forma revenue -18.1% YoY, largely from the completion of projects and client exits; underlying decline -8.3% ex one-time project .
    • Technology segment revenue down 10.2% YoY pro forma due to expected project completions and some customer exits .
    • No guidance this quarter amid integration complexity, limiting estimate anchoring and forward visibility .

Financial Results

Headline performance versus prior year

MetricQ3 2024Q3 2025
Pro Forma Revenue ($USD Millions)$269.2 $220.4
Pro Forma Gross Margin %20.0% 21.9%
Pro Forma Adjusted EBITDA ($USD Millions)$23.0 $24.7
Adjusted EBITDA Margin %11.2%
Adjusted EBITDA Margin YoY Change (bps)+260

As reported (partial-quarter consolidation) versus prior year

MetricQ3 2024Q3 2025
Revenue ($USD Millions)$233.4 $209.1
Gross Margin %18.9% 22.0%

Segment breakdown – Pro Forma

SegmentQ3 2024 Revenue ($USD Millions)Q3 2025 Revenue ($USD Millions)Q3 2024 Gross Margin %Q3 2025 Gross Margin %
Applied Workflow Automation$245.2 $198.9 15.7% 17.3%
Technology$24.0 $21.5 63.7% 64.3%
Total$269.2 $220.4 20.0% 21.9%

Segment breakdown – As Reported

SegmentQ3 2024 Revenue ($USD Millions)Q3 2025 Revenue ($USD Millions)Q3 2024 Gross Margin %Q3 2025 Gross Margin %
Applied Workflow Automation$220.3 $189.4 16.0% 17.7%
Technology$13.1 $19.7 67.9% 62.9%
Total$233.4 $209.1 18.9% 22.0%

Key performance indicators

KPIValue
Pro Forma TTM Revenue ($USD Millions)$916.4
Pro Forma TTM Adjusted EBITDA ($USD Millions)$103.6
Net Leverage (Pro Forma TTM)~3.37x

Balance sheet snapshot (as of Sep 30, 2025)

MetricQ3 2025
Cash and Cash Equivalents ($USD Millions)$34.5
Total Assets ($USD Millions)$947.9
Total Liabilities ($USD Millions)$817.4
Stockholders’ Equity ($USD Millions)$130.5
Current Portion of Long-Term Debt ($USD Millions)$34.9
Long-Term Debt, net ($USD Millions)$346.6

Notes:

  • Reported results exclude XBP Europe until July 29 and treat Exela BPA as the accounting acquirer; management provided pro forma to facilitate comparisons .

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Company GuidanceFY/QuarterNoneNo formal guidance this quarter; management expects to provide guidance in future periods Maintained (no guidance)

Earnings Call Themes & Trends

TopicPrevious Mentions (Q-2 and Q-1)Current Period (Q3 2025)Trend
AI/technology initiativesContinued margin improvement and adjusted EBITDA growth; integration of BPA expected to provide scale; GM 29.8% in Q2 “Automation rate of up to 70%-75%” in marquee accounts; revenue/employee >$80k; hybrid agentic AI (IDP + human-in-loop) Acceleration and operationalization of AI across workflows
Sales pipeline and client winsMomentum in core segments; sequential revenue growth; European focus pre-close New NYC Department of Finance lockbox win; multi-year insurance re-mail processing; declines moderating Early signs of pipeline rebuild and win-back post-close
Macro/clients and revenue mixStabilization and project ramp-ups cited in Q2 Revenue declines due to project completions and client exits; underlying decline -8.3% ex one-off Normalization from non-recurring tailwinds in prior year
Balance sheet/leverageAnticipated stronger balance sheet post-transaction Pro forma TTM net leverage ~3.37x (below R2000 avg); improved capital structure Deleveraging and improved financing profile
Regulatory/legalTransaction approvals and emergence from Chapter 11 for BPA Completed restructuring; broadened governance and shareholder base Governance strengthened; integration ongoing

Note: Q-1 commentary is limited due to structural change pre-acquisition; Q2 investor materials provide pre-close context .

Management Commentary

  • CEO: “With our global scale, sustainable capital structure, enhanced corporate governance, and mission-critical workflow automation solutions powered by expanded agentic AI capabilities, we are thoroughly excited for the future… positioning our organization for growth” .
  • CFO: “Pro forma revenue… $220.4 million (-18.1% YoY)… excluding a one-time… $36.5 million… decline was 8.3%… pro forma gross margin expanded to 21.9% (+190 bps YoY)… pro forma adjusted EBITDA was $24.6 million (+7.1% YoY)… adjusted EBITDA margin… 11.2% (+260 bps YoY)” .
  • CFO on segment dynamics: “Applied workflow automation… revenue decline of 18.9% YoY; excluding the client notification project… 8%… gross margins… grew… to 17.3%. Technology revenue declined 10.2% YoY due to completion of several one-time projects and exits of certain customers” .
  • CEO on AI: “In marquee AI-enabled accounts, we’re achieving automation rates of up to 70%-75%… hybrid agentic AI workflow with human-in-the-loop” .

Q&A Highlights

  • The call concluded without a Q&A session; the operator noted there were no questions in queue .
  • Management clarified they are not providing guidance this quarter given the timing of the transaction but expect to do so in future .

Estimates Context

  • Wall Street consensus via S&P Global (revenue, EPS, EBITDA, target price, recommendation) was unavailable for XBP at the time of this report; therefore, comparisons to consensus could not be made. Values retrieved from S&P Global.*

Key Takeaways for Investors

  • Underlying performance is better than headline YoY decline: excluding last year’s $36.5M one-time project, revenue fell 8.3% YoY while margins expanded materially (GM +190 bps; adj. EBITDA margin +260 bps) — signaling operational improvement despite lower volumes .
  • Structural margin drivers appear durable: automation and operating leverage lifted pro forma GM to 21.9% and adj. EBITDA to $24.7M; margin gains are evident across Applied Workflow Automation (+160 bps GM YoY) and Technology (+60 bps GM YoY) .
  • Commercial traction building: announced wins (NYC Dept. of Finance lockbox; insurance re-mail processing) and commentary on moderating declines suggest improving sales momentum and potential re-acceleration ahead .
  • Balance sheet reset post-BPA restructuring: pro forma TTM net leverage ~3.37x and broadened institutional ownership/board independence reduce financial risk and enhance strategic flexibility .
  • Near-term trading implications: Absent guidance/consensus, the stock may trade on margin progression and contract flow; watch subsequent quarters for sequential revenue stabilization alongside sustained margin expansion .
  • Medium-term thesis: Scale plus AI-driven efficiency across mission-critical workflows, diversified sector footprint, and improving governance set up for EBITDA accretion with revenue recovery; monitor conversion of pipeline and segment mix shifts (Technology lumpy but high margin) .
  • Risks: Client concentration dynamics and procurement diversification post-BPA; integration execution; prior listing compliance notices; and absence of guidance could heighten uncertainty until more quarters of combined reporting are available .

Sources: Q3 2025 8-K press release and exhibits , Q3 2025 earnings call transcript , Q2 2025 press release/investor materials , and acquisition press release/8-K .